Cantor Fitzgerald Initiates Coverage On Trulieve Cannabis with Overweight Rating, Announces Price Target of $15

Benzinga Newsdesk www.benzinga.com Neutral 54.1%

Neg 0% Neu 54.1% Pos 0%

Cantor Fitzgerald analyst Gabie Ingoglia initiates coverage on Trulieve Cannabis (NYSE:TRLV) with a Overweight rating and announces Price Target of $15.